Evidence map›Paper›PMID 29171037›Full record

ArticleHepatology (Baltimore, Md.)2018

Stochastic phenotype switching leads to intratumor heterogeneity in human liver cancer.

Andrija Matak, Pooja Lahiri, Ethan Ford, Daniela Pabst, Karl Kashofer, Dimitris Stellas, Dimitris Thanos, Kurt Zatloukal

Open access · hybridAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. MicroRNA Control of TGF-β Signaling.International journal of molecular sciences · 2018
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Andrija MatakInstitute of Pathology, Medical University of Graz, Graz, Austria.
Pooja LahiriInstitute of Pathology, Medical University of Graz, Graz, Austria.
Ethan FordUniversity of Western Australia, Crawley, WA, Australia.
Daniela PabstInstitute of Pathology, Medical University of Graz, Graz, Austria.
Karl KashoferInstitute of Pathology, Medical University of Graz, Graz, Austria.
Dimitris StellasBiomedical Research Foundation, Academy of Athens, Athens, Greece.
Dimitris ThanosBiomedical Research Foundation, Academy of Athens, Athens, Greece.
Kurt ZatloukalInstitute of Pathology, Medical University of Graz, Graz, Austria.
Medical University of Graz · ATAcademy of Athens · GRUniversity of Western Australia · AU

Funding

Austrian Science Fund FWF W 1226
6 · The paper itself

Abstract

Intratumor heterogeneity is increasingly recognized as a major factor impacting diagnosis and personalized treatment of cancer. We characterized stochastic phenotype switching as a mechanism contributing to intratumor heterogeneity and malignant potential of liver cancer. Clonal analysis of primary tumor cell cultures of a human sarcomatoid cholangiocarcinoma identified different types of self-propagating subclones characterized by stable (keratin-7-positive or keratin-7-negative) phenotypes and an unstable phenotype consisting of mixtures of keratin-7-positive and keratin-7-negative cells, which lack stem cell features but may reversibly switch their phenotypes. Transcriptome sequencing and immunohistochemical studies with the markers Zeb1 and CD146/MCAM demonstrated that switching between phenotypes is linked to changes in gene expression related but not identical to epithelial-mesenchymal transition. Stochastic phenotype switching occurred during mitosis and did not correlate with changes in DNA methylation. Xenotransplantation assays with different cellular subclones demonstrated increased tumorigenicity of cells showing phenotype switching, resulting in tumors morphologically resembling the invasive component of primary tumor and metastasis.

conclusionOur data demonstrate that stochastic phenotype switching contributes to intratumor heterogeneity and that cells with a switching phenotype have increased malignant potential. (Hepatology 2017).

Indexed as

Genes, SwitchGenetic HeterogeneityCholangiocarcinomaHumansLiver NeoplasmsPhenotypeStochastic ProcessesTumor Cells, Cultured

Identifiers

PMID29171037
PMCPMC6175233
OpenAlexW2770249692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.